EPISODE · Apr 11, 2025 · 1H 6M
124. Cell-ebrating Success: Ilan Sobel Blends Science and Strategy to Scale-up BioHarvest
from Grow Everything Biotech Podcast · host Messaginglab
What if you could grow health-boosting compounds—not in fields, but in bioreactors—using the power of plant cells? In this episode, Karl and Erum sit down with Ilan Sobel, CEO of BioHarvest, to explore how the company is reshaping biotech, nutraceuticals, and biomanufacturing. From leveraging botanical synthesis to create highly bioavailable compounds like piceid resveratrol, to scaling sustainable DTC operations that rival software margins, Ilan reveals how BioHarvest is closing the gap between nature, science, and commerce. Hear how this Coca-Cola veteran is building a biological infrastructure poised to disrupt pharma, food, and beyond—one cell at a time.Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing?Learn more at www.messaginglab.com/groweverything Chapters:00:00:00 - Kicking Off with Biotech That Prints Money00:00:21 - $9 Trillion Vanishes: Markets, Mayhem, and Monday Mood00:00:36 - Brooklyn Birthdays, Bio Buzz & Citizen Scientists Unite00:02:24 - Tariffs, Pharma, and the Future of Drug Supply Chains00:04:20 - Reddit Rabbit Holes and Underrated Science That Could Change Everything00:06:49 - Pharma’s Dirty Secret: Why Cures Don’t Always Win00:09:39 - Meet Ilan Sobel: From Coca-Cola Exec to Biotech World-Changer00:19:13 - What the Heck Is Botanical Synthesis? (And Why It’s a Game-Changer)00:26:46 - Tiny Footprint, Massive Impact: Economics That Would Make Silicon Valley Jealous00:29:02 - How a Grape Cell Became the King of Blood Flow Supplements00:35:09 - Why Longevity Starts with Blood, Not Kale00:37:32 - The Secret Sauce Behind Supplements That Actually Work00:38:55 - How BioHarvest Orchestrated a Biotech Masterpiece00:40:20 - From Plant Cells to Profit: Scaling Biotech Like a Pro00:43:10 - Open Sourcing the Future: CDMO Deals with Global Impact00:48:47 - Making Sweeteners Smarter (And Actually Tasty)00:51:35 - Building the Tesla of Biomanufacturing—Globally00:57:39 - What’s Next for BioHarvest? Legacy, Longevity, and Global ScaleLinks and Resources:BioHarvestVinia.comPwC’s US Tariff Industry Analysis – Pharmaceutical, Life Science, and Medical DeviceReddit: Scientific Ideas that haven’t gotten enough tractionCommon Side Effects (tv series)Genesis Machine (book)Topics Covered: biomanufacturing, botanical cellular synthesis, plant biology, phytonutrients, sweet proteins, distributed biomanufacturing, direct to consumer biotechHave a question or comment? Message us here:Text or Call (804) 505-5553 Instagram / Twitter / LinkedIn / Youtube / Grow EverythingEmail: [email protected] by: NihiloreProduction by: Amplafy Media
What this episode covers
What if you could grow health-boosting compounds—not in fields, but in bioreactors—using the power of plant cells? In this episode, Karl and Erum sit down with Ilan Sobel, CEO of BioHarvest, to explore how the company is reshaping biotech, nutraceuticals, and biomanufacturing. From leveraging botanical synthesis to create highly bioavailable compounds like piceid resveratrol, to scaling sustainable DTC operations that rival software margins, Ilan reveals how BioHarvest is closing the gap between nature, science, and commerce. Hear how this Coca-Cola veteran is building a biological infrastructure poised to disrupt pharma, food, and beyond—one cell at a time.Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing?Learn more at www.messaginglab.com/groweverything Chapters:00:00:00 - Kicking Off with Biotech That Prints Money00:00:21 - $9 Trillion Vanishes: Markets, Mayhem, and Monday Mood00:00:36 - Brooklyn Birthdays, Bio Buzz & Citizen Scientists Unite00:02:24 - Tariffs, Pharma, and the Future of Drug Supply Chains00:04:20 - Reddit Rabbit Holes and Underrated Science That Could Change Everything00:06:49 - Pharma’s Dirty Secret: Why Cures Don’t Always Win00:09:39 - Meet Ilan Sobel: From Coca-Cola Exec to Biotech World-Changer00:19:13 - What the Heck Is Botanical Synthesis? (And Why It’s a Game-Changer)00:26:46 - Tiny Footprint, Massive Impact: Economics That Would Make Silicon Valley Jealous00:29:02 - How a Grape Cell Became the King of Blood Flow Supplements00:35:09 - Why Longevity Starts with Blood, Not Kale00:37:32 - The Secret Sauce Behind Supplements That Actually Work00:38:55 - How BioHarvest Orchestrated a Biotech Masterpiece00:40:20 - From Plant Cells to Profit: Scaling Biotech Like a Pro00:43:10 - Open Sourcing the Future: CDMO Deals with Global Impact00:48:47 - Making Sweeteners Smarter (And Actually Tasty)00:51:35 - Building the Tesla of Biomanufacturing—Globally00:57:39 - What’s Next for BioHarvest? Legacy, Longevity, and Global ScaleLinks and Resources:BioHarvestVinia.comPwC’s US Tariff Industry Analysis – Pharmaceutical, Life Science, and Medical DeviceReddit: Scientific Ideas that haven’t gotten enough tractionCommon Side Effects (tv series)Genesis Machine (book)Topics Covered: biomanufacturing, botanical cellular synthesis, plant biology, phytonutrients, sweet proteins, distributed biomanufacturing, direct to consumer biotechHave a question or comment? Message us here:Text or Call (804) 505-5553 Instagram / Twitter / LinkedIn / Youtube / Grow EverythingEmail: [email protected] by: NihiloreProduction by: Amplafy Media
NOW PLAYING
124. Cell-ebrating Success: Ilan Sobel Blends Science and Strategy to Scale-up BioHarvest
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m